21.77
price down icon4.68%   -1.07
after-market Dopo l'orario di chiusura: 21.70 -0.07 -0.32%
loading
Precedente Chiudi:
$22.84
Aprire:
$22.5
Volume 24 ore:
643.69K
Relative Volume:
0.83
Capitalizzazione di mercato:
$1.31B
Reddito:
$439.00K
Utile/perdita netta:
$-105.64M
Rapporto P/E:
-12.09
EPS:
-1.8
Flusso di cassa netto:
$-60.70M
1 W Prestazione:
-10.78%
1M Prestazione:
-5.39%
6M Prestazione:
-29.39%
1 anno Prestazione:
-54.54%
Intervallo 1D:
Value
$21.73
$22.86
Intervallo di 1 settimana:
Value
$21.73
$24.54
Portata 52W:
Value
$21.73
$71.71

Janux Therapeutics Inc Stock (JANX) Company Profile

Name
Nome
Janux Therapeutics Inc
Name
Telefono
(858) 751-4493
Name
Indirizzo
10955 VISTA SORRENTO PARKWAY, SAN DIEGO
Name
Dipendente
103
Name
Cinguettio
Name
Prossima data di guadagno
2024-08-06
Name
Ultimi documenti SEC
Name
JANX's Discussions on Twitter

Confronta JANX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
JANX
Janux Therapeutics Inc
21.77 1.37B 439.00K -105.64M -60.70M -1.80
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
381.87 96.56B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
449.58 60.08B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
555.51 61.15B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
711.09 44.66B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
328.71 36.23B 3.81B -644.79M -669.77M -6.24

Janux Therapeutics Inc Stock (JANX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-09-17 Iniziato Barclays Overweight
2025-09-10 Iniziato Stifel Buy
2025-09-10 Iniziato Truist Buy
2025-09-04 Iniziato Guggenheim Buy
2025-08-19 Iniziato Piper Sandler Overweight
2025-07-11 Iniziato Raymond James Outperform
2024-12-03 Reiterato BTIG Research Buy
2024-12-03 Reiterato H.C. Wainwright Buy
2024-11-22 Iniziato Leerink Partners Outperform
2024-10-24 Iniziato UBS Buy
2024-09-06 Iniziato Stifel Buy
2024-05-30 Iniziato Scotiabank Sector Perform
2024-03-21 Iniziato BTIG Research Buy
2024-03-20 Iniziato Cantor Fitzgerald Overweight
2023-04-06 Iniziato Wedbush Outperform
2022-11-14 Iniziato William Blair Outperform
Mostra tutto

Janux Therapeutics Inc Borsa (JANX) Ultime notizie

pulisher
04:13 AM

Janux Therapeutics stock hits 52-week low at 21.97 USD - Investing.com

04:13 AM
pulisher
Sep 22, 2025

Janux Therapeutics (NASDAQ:JANX) Coverage Initiated by Analysts at Barclays - MarketBeat

Sep 22, 2025
pulisher
Sep 22, 2025

Top 5 Oncology Stocks to Watch According to Barclays By Investing.com - Investing.com Canada

Sep 22, 2025
pulisher
Sep 22, 2025

Janux Therapeutics (NASDAQ:JANX) Earns Overweight Rating from Analysts at Barclays - MarketBeat

Sep 22, 2025
pulisher
Sep 22, 2025

Janux Therapeutics (NASDAQ:JANX) Shares Gap UpTime to Buy? - MarketBeat

Sep 22, 2025
pulisher
Sep 20, 2025

Institution Moves: Will Denison Mines Corp stock benefit from M A2025 Earnings Impact & Real-Time Chart Pattern Alerts - خودرو بانک

Sep 20, 2025
pulisher
Sep 20, 2025

Janux Therapeutics Announces Departure of Chief Strategy Officer - The Globe and Mail

Sep 20, 2025
pulisher
Sep 20, 2025

Janux Therapeutics chief strategy officer departs in company-initiated move By Investing.com - Investing.com Nigeria

Sep 20, 2025
pulisher
Sep 19, 2025

Janux Therapeutics chief strategy officer departs in company-initiated move - Investing.com

Sep 19, 2025
pulisher
Sep 19, 2025

Big Money Moves: Is Janux Therapeutics Inc. stock a buy or sell2025 Analyst Calls & Technical Pattern Based Signals - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Janux Therapeutics, Inc. $JANX Shares Sold by Goldman Sachs Group Inc. - MarketBeat

Sep 19, 2025
pulisher
Sep 18, 2025

Momentum Shift: Is MGRM forming bullish engulfing patternsCEO Change & Free Expert Verified Stock Movement Alerts - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

Aug Closing: Can Janux Therapeutics Inc generate free cash flowPortfolio Return Report & Real-Time Stock Entry Alerts - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

US Market Wrap: Whats the fair value of Achieve Life Sciences Inc stockChart Signals & Smart Investment Allocation Tips - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

Aug Ideas: Is NetApp Inc subject to activist investor interestQuarterly Trade Review & Weekly Watchlist for Consistent Profits - خودرو بانک

Sep 18, 2025
pulisher
Sep 17, 2025

Investment Review: What is Janux Therapeutics Incs valuation compared to sectorOil Prices & Free Verified High Yield Trade Plans - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

Momentum Shift: Should you avoid CBFV stock right nowMarket Performance Report & Risk Controlled Swing Trade Alerts - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

Barclays Initiates Coverage on JANX with Overweight Rating | JAN - GuruFocus

Sep 17, 2025
pulisher
Sep 17, 2025

Barclays Initiates Coverage of Janux Therapeutics (JANX) with Overweight Recommendation - Nasdaq

Sep 17, 2025
pulisher
Sep 17, 2025

Bernstein Initiates Janux Therapeutics at Overweight With $47 Price Target - MarketScreener

Sep 17, 2025
pulisher
Sep 16, 2025

Janux Therapeutics initiated with an Overweight at Barclays - TipRanks

Sep 16, 2025
pulisher
Sep 16, 2025

Highs Report: Is HCKT forming bullish engulfing patternsMarket Trend Report & Expert Verified Movement Alerts - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Aug Swings: Should I hold or sell INNOVATE Corp. Equity Right now2025 Support & Resistance & Free High Accuracy Swing Entry Alerts - khodrobank.com

Sep 16, 2025
pulisher
Sep 15, 2025

Market Fear: What is Janux Therapeutics Incs valuation compared to sectorWeekly Risk Summary & AI Powered Trade Plan Recommendations - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Truist Initiates Coverage on Janux Therapeutics (JANX) with a Buy Rating, $100 PT - Yahoo Finance

Sep 15, 2025
pulisher
Sep 15, 2025

Janux Therapeutics (NASDAQ:JANX) Coverage Initiated at Truist Financial - MarketBeat

Sep 15, 2025
pulisher
Sep 15, 2025

Woodline Partners LP Has $39.34 Million Holdings in Janux Therapeutics, Inc. $JANX - MarketBeat

Sep 15, 2025
pulisher
Sep 14, 2025

Janux Therapeutics Inc. recovery potential after sell off2025 Market Outlook & Low Risk Profit Maximizing Plans - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Analyzing recovery setups for Janux Therapeutics Inc. investorsWeekly Risk Report & Fast Exit Strategy with Risk Control - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Statistical indicators supporting Janux Therapeutics Inc.’s strengthTrade Analysis Report & Daily Risk Controlled Trade Plans - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Visualizing Janux Therapeutics Inc. stock with heatmaps2025 Price Targets & Smart Money Movement Alerts - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Comparing Janux Therapeutics Inc. in custom built stock radars2025 Dividend Review & Free High Accuracy Swing Entry Alerts - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

How hedge fund analytics apply to Janux Therapeutics Inc. stockExit Point & Weekly Momentum Picks - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

10 Best Up and Coming Stocks with Huge Upside Potential - Insider Monkey

Sep 14, 2025
pulisher
Sep 13, 2025

Institutional scanner results for Janux Therapeutics Inc.Market Risk Analysis & High Conviction Investment Ideas - newser.com

Sep 13, 2025
pulisher
Sep 13, 2025

Short interest data insights for Janux Therapeutics Inc.Take Profit & Intraday High Probability Setup Alerts - Newser

Sep 13, 2025
pulisher
Sep 12, 2025

Cubist Systematic Strategies LLC Has $2.05 Million Position in Janux Therapeutics, Inc. $JANX - MarketBeat

Sep 12, 2025
pulisher
Sep 12, 2025

Bank of America Securities Remains a Buy on Janux Therapeutics Inc (JANX) - The Globe and Mail

Sep 12, 2025
pulisher
Sep 12, 2025

Possible Bearish Signals With Janux Therapeutics Insiders Disposing Stock - 富途牛牛

Sep 12, 2025
pulisher
Sep 12, 2025

Stifel Nicolaus Reaffirms “Buy” Rating for Janux Therapeutics (NASDAQ:JANX) - Defense World

Sep 12, 2025
pulisher
Sep 11, 2025

BofA Securities Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $59 - 富途牛牛

Sep 11, 2025
pulisher
Sep 11, 2025

Janux Therapeutics (NASDAQ:JANX) Coverage Initiated at Guggenheim - MarketBeat

Sep 11, 2025
pulisher
Sep 10, 2025

Alyeska Investment Group L.P. Purchases 63,762 Shares of Janux Therapeutics, Inc. $JANX - MarketBeat

Sep 10, 2025
pulisher
Sep 10, 2025

Janux stock a new Buy at Truist on H2 catalysts (JANX:NASDAQ) - Seeking Alpha

Sep 10, 2025
pulisher
Sep 10, 2025

Truist Initiates Janux Therapeutics at Buy With $100 Price Target - MarketScreener

Sep 10, 2025
pulisher
Sep 10, 2025

Janux Therapeutics initiated with a Buy at Truist - TipRanks

Sep 10, 2025
pulisher
Sep 10, 2025

Buy Rating for Janux Therapeutics Inc: Promising Oncology Innovations and Strategic Advancements - TipRanks

Sep 10, 2025
pulisher
Sep 10, 2025

Janux Therapeutics resumed with a Buy at Stifel - TipRanks

Sep 10, 2025
pulisher
Sep 10, 2025

Stifel resumes Janux Therapeutics stock coverage with Buy rating By Investing.com - Investing.com Canada

Sep 10, 2025
pulisher
Sep 09, 2025

Walleye Capital LLC Makes New Investment in Janux Therapeutics, Inc. $JANX - MarketBeat

Sep 09, 2025
pulisher
Sep 09, 2025

Analysts Set Janux Therapeutics, Inc. (NASDAQ:JANX) PT at $86.90 - MarketBeat

Sep 09, 2025

Janux Therapeutics Inc Azioni (JANX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$34.90
price down icon 2.43%
$81.66
price down icon 2.97%
$28.84
price down icon 2.07%
$98.08
price down icon 1.67%
$135.59
price down icon 3.84%
biotechnology ONC
$328.71
price down icon 0.34%
Capitalizzazione:     |  Volume (24 ore):